ArticleEMBO reports2024

Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication.

Pasqualino de Antonellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.